Deutsche Bank AG boosted its position in shares of Envision Healthcare Co. (NYSE:EVHC) by 44.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,043,287 shares of the company’s stock after buying an additional 321,856 shares during the period. Deutsche Bank AG owned approximately 0.86% of Envision Healthcare worth $36,053,000 as of its most recent SEC filing.
Other hedge funds also recently modified their holdings of the company. Wells Fargo & Company MN raised its position in Envision Healthcare by 11.2% during the third quarter. Wells Fargo & Company MN now owns 917,418 shares of the company’s stock valued at $41,238,000 after purchasing an additional 92,339 shares during the period. OZ Management LP purchased a new stake in Envision Healthcare during the third quarter valued at approximately $131,987,000. Hexavest Inc. raised its position in Envision Healthcare by 1.1% during the fourth quarter. Hexavest Inc. now owns 655,516 shares of the company’s stock valued at $22,655,000 after purchasing an additional 7,270 shares during the period. Swiss National Bank raised its position in Envision Healthcare by 2.1% during the fourth quarter. Swiss National Bank now owns 442,116 shares of the company’s stock valued at $15,280,000 after purchasing an additional 9,200 shares during the period. Finally, Quantitative Systematic Strategies LLC raised its position in Envision Healthcare by 17.9% during the fourth quarter. Quantitative Systematic Strategies LLC now owns 14,319 shares of the company’s stock valued at $495,000 after purchasing an additional 2,169 shares during the period.
Shares of Envision Healthcare Co. (NYSE EVHC) opened at $39.01 on Friday. The company has a quick ratio of 3.38, a current ratio of 3.40 and a debt-to-equity ratio of 0.87. Envision Healthcare Co. has a fifty-two week low of $23.77 and a fifty-two week high of $66.39. The firm has a market capitalization of $4,717.28, a P/E ratio of -18.85, a PEG ratio of 0.97 and a beta of 0.48.
Envision Healthcare (NYSE:EVHC) last issued its quarterly earnings results on Tuesday, February 27th. The company reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.45 by $0.14. Envision Healthcare had a positive return on equity of 4.62% and a negative net margin of 2.52%. The firm had revenue of $2 billion for the quarter, compared to the consensus estimate of $1.97 billion. During the same period in the prior year, the business posted $1.15 earnings per share. The company’s revenue for the quarter was up 68.0% on a year-over-year basis. research analysts anticipate that Envision Healthcare Co. will post 3.34 EPS for the current year.
EVHC has been the topic of a number of recent research reports. Jefferies Group set a $46.00 price objective on Envision Healthcare and gave the company a “buy” rating in a research report on Thursday. Robert W. Baird set a $45.00 price objective on Envision Healthcare and gave the company a “buy” rating in a research report on Monday, February 26th. Cantor Fitzgerald restated a “hold” rating and set a $37.00 price objective on shares of Envision Healthcare in a research report on Friday, January 5th. Stephens restated a “hold” rating and set a $34.00 price objective on shares of Envision Healthcare in a research report on Wednesday, January 10th. Finally, ValuEngine downgraded Envision Healthcare from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and nine have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $42.57.
TRADEMARK VIOLATION WARNING: This article was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The correct version of this article can be accessed at https://ledgergazette.com/2018/03/18/deutsche-bank-ag-increases-position-in-envision-healthcare-co-evhc.html.
Envision Healthcare Company Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Co. (NYSE:EVHC).
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.